President Uhuru Kenyatta was part of a teleconference call involving 10 African Heads of State that discussed the adoption of Covid-19 organic medicine.
The meeting on Saturday, May 2, was held to discuss in detail the efficacy of the Covid Organics Medicine(CVO) that was developed by Madagascar in treating Covid-19 patients.
The President of Madagascar, Andry Rajoelina took to Twitter on Monday, April 20, to claim that the concoction named Covid Organics (CVO) – a form of herbal tea – is curing Covid-19 patients.
World Health Organization (WHO) however in a statement warned against any self-medication and said that it has not recommended any medicine as a cure for the Covid-19.
Malagasy President, chaired the meeting and presented the product to the other Heads of States in the video conference call.
Presidents present in the meeting were, Cyril Ramaphosa (African Union Chairperson and South Africa), Abdul Fatah El Sisi (Egypt), President Felix Tshisekedi(DRC), President Uhuru Kenyatta (Kenya).
Paul Kagame (Rwanda), Ali Bongo (Gabon), Mahamadou Issoufou (Niger), Idris Derby (Chad), Boubacar Keita (Mali) and Andry Rajoelina (Madagascar).
They also formed a Covid-19 Ministerial Response Coordinating Committees on Health, Transport, Finance and Agriculture to respond to the various factors surrounding the Coronavirus pandemic.
The Bureau of Heads of State of the African Union also formulated a continental strategy to better prepare and respond to any new cases of the virus on the continent.
The meeting also shared experimental drugs on the deadly virus, vaccines and clinical trials that have kicked off around the world.
Kenya was earmarked as a testing ground for the United Kingdom Covid-19 vaccine but Uhuru denied knowledge of the plans.
The Heads of State formed the Africa Union Covid-19 Fund, done under the Africa Centres for Disease Control and Prevention (Africa CDC).
The fund is a public-private partnership that aims to raise an initial $150 million (Ksh16 billion) for immediate needs to prevent transmission and up to $400 million (Ksh52 billion) to support sustainable medical response to the COVID-19 pandemic.
{"preview_thumbnail":"/files/styles/video_embed_wysiwyg_preview/public/video_thumbnails/x7tnz06.jpg?itok=ReZcfhBO","video_url":"","settings":{"responsive":1,"width":"854","height":"480","autoplay":0},"settings_summary":["Embedded Video (Responsive)."]}
